IRIS
CLERICO, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.942
EU - Europa 34.494
AS - Asia 20.848
SA - Sud America 3.509
AF - Africa 407
Continente sconosciuto - Info sul continente non disponibili 203
OC - Oceania 32
Totale 112.435
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.664
GB - Regno Unito 14.484
SG - Singapore 7.769
RU - Federazione Russa 6.676
CN - Cina 5.990
UA - Ucraina 3.966
VN - Vietnam 3.117
BR - Brasile 2.815
DE - Germania 2.431
IT - Italia 2.231
HK - Hong Kong 1.916
CA - Canada 980
FI - Finlandia 933
SE - Svezia 914
FR - Francia 865
DK - Danimarca 784
PL - Polonia 639
IN - India 369
IL - Israele 272
AR - Argentina 241
BD - Bangladesh 238
IE - Irlanda 203
EU - Europa 202
MX - Messico 196
ZA - Sudafrica 154
TR - Turchia 149
IQ - Iraq 145
ID - Indonesia 140
EC - Ecuador 110
JP - Giappone 96
VE - Venezuela 92
PK - Pakistan 88
CO - Colombia 86
NL - Olanda 85
SA - Arabia Saudita 67
CL - Cile 61
ES - Italia 61
UZ - Uzbekistan 61
KR - Corea 60
MA - Marocco 56
MY - Malesia 50
PH - Filippine 43
RO - Romania 38
AE - Emirati Arabi Uniti 35
PY - Paraguay 35
JO - Giordania 34
TN - Tunisia 34
KE - Kenya 33
LT - Lituania 33
UY - Uruguay 32
EG - Egitto 30
NP - Nepal 29
AT - Austria 25
DZ - Algeria 25
AU - Australia 22
ET - Etiopia 21
JM - Giamaica 19
AZ - Azerbaigian 18
PE - Perù 18
SK - Slovacchia (Repubblica Slovacca) 18
IR - Iran 15
TH - Thailandia 15
KZ - Kazakistan 14
PA - Panama 14
OM - Oman 13
RS - Serbia 13
BH - Bahrain 12
BO - Bolivia 12
AL - Albania 11
DO - Repubblica Dominicana 11
NI - Nicaragua 11
PS - Palestinian Territory 11
TT - Trinidad e Tobago 11
TW - Taiwan 11
BY - Bielorussia 9
CR - Costa Rica 9
CZ - Repubblica Ceca 9
HN - Honduras 9
LB - Libano 9
PT - Portogallo 9
BE - Belgio 8
CI - Costa d'Avorio 8
KW - Kuwait 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
QA - Qatar 8
AM - Armenia 7
AO - Angola 7
BG - Bulgaria 7
HR - Croazia 7
SN - Senegal 7
CH - Svizzera 6
KH - Cambogia 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
HU - Ungheria 5
KG - Kirghizistan 5
PR - Porto Rico 5
BW - Botswana 4
CY - Cipro 4
Totale 112.354
Salva come PNG Salva come JPEG
Città #
Southend 12.638
Dallas 8.280
Woodbridge 5.122
Ann Arbor 4.000
Singapore 3.495
Chandler 3.260
Houston 3.010
San Mateo 2.512
Beijing 2.371
San Jose 2.265
Ashburn 2.169
Dearborn 1.956
Jacksonville 1.922
Hong Kong 1.815
Falls Church 1.474
Moscow 1.402
Fairfield 1.187
The Dalles 1.150
Seattle 1.059
Cambridge 948
Wilmington 835
Dong Ket 828
Stevenage 761
Portsmouth 693
Hefei 689
Boardman 664
Warsaw 623
Lawrence 611
Ho Chi Minh City 562
Lauterbourg 560
Brooklyn 523
Los Angeles 486
Pisa 469
Ottawa 459
Chicago 407
Hanoi 398
Helsinki 297
Santa Clara 296
São Paulo 269
Tel Aviv 249
Buffalo 243
Council Bluffs 210
New York 210
Montréal 195
Dublin 189
Old Bridge 185
Salt Lake City 175
San Diego 137
Beauharnois 107
Redwood City 101
Rio de Janeiro 100
Munich 99
Mexico City 98
Norwalk 95
Orem 89
London 87
Johannesburg 86
Montreal 86
Tampa 86
Da Nang 85
Chennai 83
Rome 82
Tokyo 82
Milan 78
Elk Grove Village 73
Stockholm 68
Haiphong 64
Belo Horizonte 60
Phoenix 56
Tashkent 54
Denver 52
Atlanta 51
Baghdad 51
Brasília 51
Dhaka 50
Frankfurt am Main 50
Boston 49
Curitiba 49
San Francisco 48
Porto Alegre 45
Guangzhou 43
Hải Dương 42
Amsterdam 40
Toronto 40
Poplar 39
Fremont 38
Istanbul 38
Augusta 37
Biên Hòa 36
Manchester 36
Quito 36
Bologna 35
Kansas City 35
Nuremberg 35
Seoul 35
Washington 35
Ankara 34
Jeddah 33
Lancaster 33
Santiago 32
Totale 77.305
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.673
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 688
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 443
siRNA-mediated targeting of endothelial VWF prevents ET-1 upregulation in porcine aortic endothelial cells chronically exposed to angiotensin II 407
Downregulation of von Willebrand Factor prevents Ang II-induced endothelin-1 expression independently of eNOS activation in porcine endothelial cells 405
Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. 396
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 334
A chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using quality control sera assayed in an interlaboratory survey 333
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 330
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 321
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study 318
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 317
125I-Endothelin-1 binding sites in human cardiac tissue 316
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 316
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 312
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 312
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina 309
A chromatographic method for the determination of uric acid turnover in man 303
A sensitive and accurate plasma noradrenaline assay using a modified fluorimetric method. 299
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 296
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides 295
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 294
A ligand-receptor binding assay of urinary and circulating endogenous digitalis-like factors 290
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 285
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 283
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 282
A chromatographic method for the determination of uric acid turnover in man 281
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 281
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 278
A simplified method of measuring free triiodothyronine in serum by conbined equilibrium dialysis and gel Sephadex extraction 278
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 277
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 277
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 273
A false positive case of cardiac troponin I: Which diagnostic approach? 271
A new chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using QC sera assayed in an interlaboratory survey 265
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 264
Marcatori di rimodellamento e fibrosi cardiaca 264
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 263
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 262
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 261
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 260
A simple, sensitive and rapid radioimmunoassay for measurement of urinary albumin 260
Direct comparison of B-Type Natriuretic Peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data 259
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 258
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 257
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients 256
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 255
A rapid procedure for the quantization of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects 254
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 251
Acute effects of intravenous amiodarone on sulphate metabolite of thyroid hormones in arrhythmic patients 251
B-type natriuretic peptide secretion following scuba diving 247
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 245
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 245
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 242
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 241
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 241
Inibizione dell'asse ipofiso-gonadale dopo trattamento con un farmaco anabolizzante (Metandrostenolone, Dianabol) 240
Methodological assessment of mitochondrial respiratory chain-enzyme activities in cardiac tissue 239
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 237
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 236
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences 236
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 235
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 235
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 234
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 234
The 99th percentile of reference population for cTnI and cTnT assay: Methodology, pathophysiology and clinical implications 233
No variation in Hsp70 mRNA level during cardiac surgery in pediatric patients evaluated by semiquantitative RT-PCR 232
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 232
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study 232
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 231
Proposta per l’utilizzo in Pronto Soccorso delle troponine cardiache misurate con metodi di ultima generazione in pazienti con sospetto di sindrome coronarica acuta senza sopraslivellamento del tratto ST 230
Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: From theory to practice 230
Evaluation of analytical performances using standardized analytical protocols and comparison of clinical results of the new ADVIA BNP and NT-proBNP immunoassays for the Centaur XPT platform 229
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 228
Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin i 227
Evaluation and Comparison with Other High-Sensitivity Methods of Analytical Performance and Measured Values of a New Laboratory Test for Cardiac Troponin I Assay 226
S-nitrosoglutathione as a substrate of gamma-glutamyltransferase (GGT)- A kinetic study 226
Cardiac troponins as biomarkers for cardiac disease 225
Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty 224
BNP values in the first days of life measured with an automated immunoassay platform 224
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 224
Comparison of two BNP immunoassays using the same antibodies and standard materials 224
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 224
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 222
Natriuretic peptide testing in primary care patients. 221
Genomic medicine and thrombotic risk: who, when, how and why? 221
New biomarkers for risk stratifications in patients with heart failure: high-sensitivity troponin I and galectin-3 221
Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. 221
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 218
Gamma-glumamyl-transferase levels are associated with inflammatory activation, myocardial dysfunction and mortality in pateints with ST-elevation myocardial infarction 218
Circulating forms of the B-type natriuretic peptide prohormone: pathophysiologic and clinical considerations 217
Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia. 216
Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases 216
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 216
Prognostic complexity of heart failure and network analysis: the holistic risk stratification 216
Plasma gamma-glutamyltransferase fractions: diagnostic and prognostic predictive value 216
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 216
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 215
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. 215
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 213
Totale 27.899
Salva come PNG Salva come JPEG
Categoria #
all - tutte 522.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 522.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.098 0 0 0 0 0 0 0 0 0 382 1.035 1.681
2021/20228.252 276 1.896 208 966 62 55 887 1.779 511 924 56 632
2022/20236.603 616 117 70 1.176 1.151 1.248 12 531 1.101 143 267 171
2023/20241.761 370 85 290 104 72 276 232 72 25 47 29 159
2024/202516.831 116 65 1.084 346 275 1.163 2.348 5.046 1.570 1.069 2.463 1.286
2025/202632.830 1.629 7.932 3.339 3.207 3.369 2.012 6.125 1.660 1.684 1.873 0 0
Totale 112.660